KOD.NASDAQKodiak Sciences INC
Form 4: Kodiak Sciences Insider Buys Shares
Sentiment:
Insider Transaction (Form 4)
Baker Bros. Advisors Lp and 5 others reported changes in beneficial ownership of Kodiak Sciences Inc. common stock on September 28, 2026.
Summary
- Open-market purchase: acquired 186 Common Stock at $86.72 ($16,130) on September 28, 2026; holds 1,629,628 after (Indirect).
- Open-market purchase: acquired 3,114 Common Stock at $86.72 ($270,051) on September 28, 2026; holds 19,519,021 after (Indirect).
- Open-market purchase: acquired 957 Common Stock at $86.81 ($83,081) on September 28, 2026; holds 1,630,585 after (Indirect).
- Open-market purchase: acquired 16,036 Common Stock at $86.81 ($1,392,153) on September 28, 2026; holds 19,535,057 after (Indirect).
- Open-market purchase: acquired 3,790 Common Stock at $86.94 ($329,511) on September 28, 2026; holds 1,634,375 after (Indirect).
- Open-market purchase: acquired 63,539 Common Stock at $86.94 ($5,524,214) on September 28, 2026; holds 19,598,596 after (Indirect).
- Open-market purchase: acquired 4,485 Common Stock at $87.51 ($392,467) on September 28, 2026; holds 1,638,860 after (Indirect).
- Open-market purchase: acquired 75,176 Common Stock at $87.51 ($6,578,389) on September 28, 2026; holds 19,673,772 after (Indirect).
- Open-market purchase: acquired 5,880 Common Stock at $88.57 ($520,775) on September 28, 2026; holds 1,644,740 after (Indirect).
- Open-market purchase: acquired 98,561 Common Stock at $88.57 ($8,729,262) on September 28, 2026; holds 19,772,333 after (Indirect).
- Open-market purchase: acquired 6,428 Common Stock at $88.65 ($569,816) on September 28, 2026; holds 1,651,168 after (Indirect).
- Open-market purchase: acquired 107,772 Common Stock at $88.65 ($9,553,557) on September 28, 2026; holds 19,880,105 after (Indirect).
- Open-market purchase: acquired 4,932 Common Stock at $89.60 ($441,925) on September 28, 2026; holds 1,656,100 after (Indirect).
- Open-market purchase: acquired 82,673 Common Stock at $89.60 ($7,407,798) on September 28, 2026; holds 19,962,778 after (Indirect).
- Open-market purchase: acquired 11,729 Common Stock at $89.86 ($1,053,915) on September 28, 2026; holds 1,667,829 after (Indirect).
- Open-market purchase: acquired 196,608 Common Stock at $89.86 ($17,666,310) on September 28, 2026; holds 20,159,386 after (Indirect).
- Open-market purchase: acquired 619 Common Stock at $84.24 ($52,146) on September 29, 2026; holds 1,668,448 after (Indirect).
- Open-market purchase: acquired 10,381 Common Stock at $84.24 ($874,517) on September 29, 2026; holds 20,169,767 after (Indirect).
- Open-market purchase: acquired 1,195 Common Stock at $85.40 ($102,057) on September 29, 2026; holds 1,669,643 after (Indirect).
- Open-market purchase: acquired 20,031 Common Stock at $85.40 ($1,710,707) on September 29, 2026; holds 20,189,798 after (Indirect).
- Open-market purchase: acquired 84 Common Stock at $85.89 ($7,214) on September 29, 2026; holds 1,669,727 after (Indirect).
- Open-market purchase: acquired 1,416 Common Stock at $85.89 ($121,614) on September 29, 2026; holds 20,191,214 after (Indirect).
Sentiment
Score: 9
Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $63,397,609, committing personal capital to the stock.
Insider Transactions
Baker Bros. Advisors Lp — Director, 10% owner
667, L.P. — Director, 10% owner
Baker Bros. Advisors (GP) LLC — Director, 10% owner
Baker Brothers Life Sciences LP — Director, 10% owner
Felix Baker — Director, 10% owner
Julian Baker — Director, 10% owner
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-28 | Open-market purchase | Common Stock | 186 | $87 | $16.1K | 1,629,628 |
| 2026-09-28 | Open-market purchase | Common Stock | 3,114 | $87 | $270.1K | 19,519,021 |
| 2026-09-28 | Open-market purchase | Common Stock | 957 | $87 | $83.1K | 1,630,585 |
| 2026-09-28 | Open-market purchase | Common Stock | 16,036 | $87 | $1.4M | 19,535,057 |
| 2026-09-28 | Open-market purchase | Common Stock | 3,790 | $87 | $329.5K | 1,634,375 |
| 2026-09-28 | Open-market purchase | Common Stock | 63,539 | $87 | $5.5M | 19,598,596 |
| 2026-09-28 | Open-market purchase | Common Stock | 4,485 | $88 | $392.5K | 1,638,860 |
| 2026-09-28 | Open-market purchase | Common Stock | 75,176 | $88 | $6.6M | 19,673,772 |
| 2026-09-28 | Open-market purchase | Common Stock | 5,880 | $89 | $520.8K | 1,644,740 |
| 2026-09-28 | Open-market purchase | Common Stock | 98,561 | $89 | $8.7M | 19,772,333 |
| 2026-09-28 | Open-market purchase | Common Stock | 6,428 | $89 | $569.8K | 1,651,168 |
| 2026-09-28 | Open-market purchase | Common Stock | 107,772 | $89 | $9.6M | 19,880,105 |
| 2026-09-28 | Open-market purchase | Common Stock | 4,932 | $90 | $441.9K | 1,656,100 |
| 2026-09-28 | Open-market purchase | Common Stock | 82,673 | $90 | $7.4M | 19,962,778 |
| 2026-09-28 | Open-market purchase | Common Stock | 11,729 | $90 | $1.1M | 1,667,829 |
| 2026-09-28 | Open-market purchase | Common Stock | 196,608 | $90 | $17.7M | 20,159,386 |
| 2026-09-29 | Open-market purchase | Common Stock | 619 | $84 | $52.1K | 1,668,448 |
| 2026-09-29 | Open-market purchase | Common Stock | 10,381 | $84 | $874.5K | 20,169,767 |
| 2026-09-29 | Open-market purchase | Common Stock | 1,195 | $85 | $102.1K | 1,669,643 |
| 2026-09-29 | Open-market purchase | Common Stock | 20,031 | $85 | $1.7M | 20,189,798 |
| 2026-09-29 | Open-market purchase | Common Stock | 84 | $86 | $7.2K | 1,669,727 |
| 2026-09-29 | Open-market purchase | Common Stock | 1,416 | $86 | $121.6K | 20,191,214 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-28 | Open-market purchase (186 shares) |
| 2026-09-28 | Open-market purchase (3,114 shares) |
| 2026-09-28 | Open-market purchase (957 shares) |
| 2026-09-28 | Open-market purchase (16,036 shares) |
| 2026-09-28 | Open-market purchase (3,790 shares) |
| 2026-09-28 | Open-market purchase (63,539 shares) |
| 2026-09-28 | Open-market purchase (4,485 shares) |
| 2026-09-28 | Open-market purchase (75,176 shares) |
| 2026-09-28 | Open-market purchase (5,880 shares) |
| 2026-09-28 | Open-market purchase (98,561 shares) |
| 2026-09-28 | Open-market purchase (6,428 shares) |
| 2026-09-28 | Open-market purchase (107,772 shares) |
| 2026-09-28 | Open-market purchase (4,932 shares) |
| 2026-09-28 | Open-market purchase (82,673 shares) |
| 2026-09-28 | Open-market purchase (11,729 shares) |
| 2026-09-28 | Open-market purchase (196,608 shares) |
| 2026-09-29 | Open-market purchase (619 shares) |
| 2026-09-29 | Open-market purchase (10,381 shares) |
| 2026-09-29 | Open-market purchase (1,195 shares) |
| 2026-09-29 | Open-market purchase (20,031 shares) |
| 2026-09-29 | Open-market purchase (84 shares) |
| 2026-09-29 | Open-market purchase (1,416 shares) |
Keywords
insider transaction, Form 4, KOD, Kodiak Sciences Inc., bullish, Baker Bros. Advisors Lp, 667, L.P., Baker Bros. Advisors (GP) LLC, Baker Brothers Life Sciences LP, Felix Baker, Julian Baker
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.